Bradlee Heckmann, Ph.D.

Bradlee Heckmann, Ph.D. is an experienced scientist and researcher specializing in molecular medicine and neuroimmunology. Bradlee is currently serving as the Co-founder & Chief Scientific Officer at Asha Therapeutics, a position they have held since November 2021. Prior to this, they worked as an Assistant Professor of Molecular Medicine at Morsani College of Medicine starting from September 2020. Bradlee also concurrently held the role of Neuroimmunologist & Principal Investigator at the USF Health Byrd Alzheimer's Institute from September 2020.

Before these roles, Dr. Heckmann served as the John H. Sununu Endowed Fellow at St. Jude Children's Research Hospital from September 2016 to September 2020. Bradlee gained valuable research experience as a Doctoral Candidate at Mayo Clinic School of Medicine from July 2012 to August 2016. Prior to pursuing their doctorate, they worked as a Research Technologist at Mayo Clinic from July 2011 to July 2012. Dr. Heckmann also served as a Ribble Research Scholar at the University of Kentucky College of Medicine from January 2008 to July 2011.

Overall, Dr. Bradlee Heckmann has built a strong background in scientific research and leadership roles within academic and medical institutions throughout their career.

Bradlee Heckmann, Ph.D. completed a Bachelor of Science (BS) degree in Biological and Physical Sciences at the University of Kentucky. Bradlee then pursued a Doctor of Philosophy (Ph.D.) degree in Biochemistry and Molecular Biology at the Mayo Clinic Alix School of Medicine from 2012 to 2016. Following that, Bradlee worked as a Postdoctoral Fellow at St. Jude Childrens Research Hospital from 2016 to 2020, focusing on Immunology under the mentorship of Dr. Douglas R. Green.